H.H. Brackmann

717 total citations
14 papers, 512 citations indexed

About

H.H. Brackmann is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, H.H. Brackmann has authored 14 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 3 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in H.H. Brackmann's work include Hemophilia Treatment and Research (10 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Virus-based gene therapy research (2 papers). H.H. Brackmann is often cited by papers focused on Hemophilia Treatment and Research (10 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Virus-based gene therapy research (2 papers). H.H. Brackmann collaborates with scholars based in Germany, United States and Czechia. H.H. Brackmann's co-authors include R. Schwaab, Johannes Oldenburg, K. Olek, Edward G. D. Tuddenham, Astrid Haack, Christian Meyer, Michael Kirchgesser, A Haack, Wolfgang Poller and Sonja Schneider-Rasp and has published in prestigious journals such as New England Journal of Medicine, Blood and Journal of Hepatology.

In The Last Decade

H.H. Brackmann

14 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H.H. Brackmann Germany 8 412 152 108 69 42 14 512
Seiki Kamisue Japan 12 532 1.3× 127 0.8× 161 1.5× 73 1.1× 77 1.8× 17 605
Douglas Drager United States 6 180 0.4× 147 1.0× 34 0.3× 97 1.4× 48 1.1× 7 317
Erin Burnett Canada 7 254 0.6× 89 0.6× 56 0.5× 71 1.0× 39 0.9× 12 352
HH Jr Kazazian United States 8 383 0.9× 230 1.5× 168 1.6× 81 1.2× 15 0.4× 8 532
Erin L. Kuether United States 11 308 0.7× 143 0.9× 50 0.5× 181 2.6× 10 0.2× 15 433
Alvin Luk China 7 339 0.8× 245 1.6× 66 0.6× 173 2.5× 73 1.7× 18 583
Jonathan S. Smythe United Kingdom 9 231 0.6× 59 0.4× 100 0.9× 45 0.7× 19 0.5× 10 371
Erica B. Esrick United States 11 204 0.5× 290 1.9× 351 3.3× 95 1.4× 23 0.5× 24 560
Barbara Ferstl Germany 10 150 0.4× 105 0.7× 57 0.5× 12 0.2× 58 1.4× 13 316
Jocelyn A. Schroeder United States 14 334 0.8× 149 1.0× 50 0.5× 181 2.6× 16 0.4× 32 491

Countries citing papers authored by H.H. Brackmann

Since Specialization
Citations

This map shows the geographic impact of H.H. Brackmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.H. Brackmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.H. Brackmann more than expected).

Fields of papers citing papers by H.H. Brackmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.H. Brackmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.H. Brackmann. The network helps show where H.H. Brackmann may publish in the future.

Co-authorship network of co-authors of H.H. Brackmann

This figure shows the co-authorship network connecting the top 25 collaborators of H.H. Brackmann. A scholar is included among the top collaborators of H.H. Brackmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.H. Brackmann. H.H. Brackmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Oldenburg, Johannes, Jörg Schröder, Jochen Graw, et al.. (2003). [Significance of mutation analysis in patients with haemophilia A].. PubMed. 23(1). 6–12. 4 indexed citations
2.
Woitas, Rainer P., Golo Ahlenstiel, Jürgen K. Rockstroh, et al.. (2001). Increased frequency of the CC-chemokine receptor 5-D32/D32 genotype in hepatitis C. Journal of Hepatology. 34. 164–164. 3 indexed citations
3.
4.
Oldenburg, Johannes, R. Schwaab, & H.H. Brackmann. (1999). Induction of Immune Tolerance in Haemophilia A Inhibitor Patients by the ‘Bonn Protocol’: Predictive Parameter for Therapy Duration and Outcome. Vox Sanguinis. 77(Suppl. 1). 49–54. 81 indexed citations
5.
Jacquemin, Marc, Roseline d’Oiron, Renaud Lavend’homme, et al.. (1999). Point mutations scattered in the FVIII C1 and C2 domains reduce FVIII binding to vWF and are associated to mild/moderate hemophilia A. 3 indexed citations
6.
Poller, Wolfgang, Sonja Schneider-Rasp, Uwe G. Liebert, et al.. (1996). Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.. PubMed. 3(6). 521–30. 46 indexed citations
7.
Mariani, Giuliano, MW Hilgartner, Arthur R. Thompson, et al.. (1995). Immune tolerance to Factor VIII:The international registry data. Advances in experimental medicine and biology. 386. 201–208. 3 indexed citations
8.
Schwaab, R., H.H. Brackmann, Christian Meyer, et al.. (1995). Haemophilia A: Mutation Type Determines Risk of Inhibitor Formation. Thrombosis and Haemostasis. 74(6). 1402–1406. 252 indexed citations
9.
Alper, Kenneth, et al.. (1995). QEEG in Hemophiliacs with HIV Infection. Clinical Electroencephalography. 26(2). 84–91. 3 indexed citations
10.
Schwaab, R., Johannes Oldenburg, Edward G. D. Tuddenham, H.H. Brackmann, & K. Olek. (1993). Mutations in haemophilia A. British Journal of Haematology. 83(3). 450–458. 19 indexed citations
11.
Gerritzen, A., et al.. (1992). Acute Hepatitis C in Haemophiliacs Due to “Virus-Inactivated” Clotting Factor Concentrates. Thrombosis and Haemostasis. 68(6). 781–781. 11 indexed citations
12.
Ludwig, Michael, et al.. (1992). Hemophilia B caused by five different nondeletion mutations in the protease domain of factor IX. Blood. 79(5). 1225–1232. 2 indexed citations
13.
Schwaab, R., Michael Ludwig, Johannes Oldenburg, et al.. (1991). Detection and characterisation of two missense mutations at a cleavage site in the factor VIII light chain. Thrombosis Research. 61(3). 225–234. 12 indexed citations
14.
Schimpf, K., H.H. Brackmann, W. Kreuz, et al.. (1989). Absence of Anti-Human Immunodeficiency Virus Types 1 and 2 Seroconversion after the Treatment of Hemophilia A or von Willebrand's Disease with Pasteurized Factor VIII Concentrate. New England Journal of Medicine. 321(17). 1148–1152. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seiki Kamisue Breakdown of academic impact, for papers by Douglas Drager Breakdown of academic impact, for papers by Erin Burnett Breakdown of academic impact, for papers by HH Jr Kazazian Breakdown of academic impact, for papers by Erin L. Kuether Breakdown of academic impact, for papers by Alvin Luk Breakdown of academic impact, for papers by Jonathan S. Smythe Breakdown of academic impact, for papers by Erica B. Esrick Breakdown of academic impact, for papers by Barbara Ferstl Breakdown of academic impact, for papers by Jocelyn A. Schroeder
Rankless by CCL
2026